Influenza Drug Information

Management of MDROs in the ICU and the role of newer antimicrobial agents

Prof. David Paterson, 30 Mar 2021

Intensive care unit (ICU) patients are at risk of developing serious infections with multidrug-resistant organisms (MDROs), which require appropriate and adequate antibiotic coverage. Early empirical coverage is pivotal in saving patients’ lives. At a recent webinar co-organized by the Society of Infectious Disease (Singapore) and Pfizer, renowned Professor David Paterson, Professor of Medicine and Director, The University of Queensland Centre for Clinical Research, and Consultant Infectious Diseases Physician, Royal Brisbane and Women’s Hospital, Brisbane, Australia, discussed the role of newer antimicrobial agents, including ceftazidime-avibactam (Zavicefta) in the management of MDROs in the ICU. Dr Wong Sin Yew, Infectious Disease Physician at Gleneagles Medical Centre and Mount Elizabeth Novena Specialist Centre, Singapore, chaired the event.

Antigen rapid tests: The new COVID-19 strategy moving forward?

Roshini Claire Anthony, 31 Jul 2021

Same-day pre-event screening for SARS-CoV-2 using antigen-detecting rapid diagnostic tests (Ag-RDT) may enable the resumption of large-scale indoor events which were halted or had their attendance capacity reduced during the COVID-19 pandemic, according to a study from Spain presented at ECCMID 2021.

Asthma management: Time for a more aggressive approach

09 Dec 2016

Asthma is a common condition prevalent in all countries of the world. To some it represents a minor, short-lived cough occurring after a viral infection; to others it is an incapacitating disease giving rise not just to morbidity but also premature death. This heterogeneity can lead to a sense of complacency and there is a need for a much improved approach to asthma to reduce unnecessary suffering. MIMS Doctor spoke to Professor Martyn Partridge who outlined a newer, more aggressive approach in asthma management.